Brief: Opsens Inc Announces 510(K) Clearance From U.S. FDA To Market Its Diastolic Pressure Algorithm
19/12/2019 12:04
Dec 19 (Reuters) - Opsens Inc OPS.TO :
* OPSENS INC - ANNOUNCES 510(K) CLEARANCE FROM U.S. FOOD AND
DRUG
ADMINISTRATION TO MARKET ITS DIASTOLIC PRESSURE ALGORITHM
Source text for Eikon: ID:nCNWvB12la
Further company coverage: OPS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe